Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

From 2005 to 2014 there was an increase in cancer center advertising expenditures

Cancer Center Advertising Costs Rose From 2005 to 2014

0
Twenty centers accounted for 86% of spending; one for-profit center accounted for 59% of spending
Overweight and obese women who lose weight via calorie restriction

Diet-Induced Weight Loss May Help Prevent CA in Obese Women

0
Corresponding drop seen in circulating VEGF, PEDF, and PAI-1
Patients who develop heart failure after myocardial infarction may also face a higher risk of cancer

Post-MI Heart Failure Linked to Increased Cancer Risk

0
However, cancer mortality rates similar for those with heart failure and those without
Statins may help lower mortality in patients with four common types of cancer

Statins Could Help Boost Survival Among Cancer Patients

0
Study found an association -- but no proof -- of prolonged survival
Short-term survival of heritable retinoblastoma is high

Retinoblastoma Mortality Up With Eye-Preserving Radiotherapy

0
Second malignancies remain major cause of death in retinoblastoma survivors
A new study indicates that 8 percent of patients -- or one in 12 -- already diagnosed with one form of cancer will develop a second type of unrelated cancer. The findings were published online  July 5 in Cancer.

Second, Unrelated Malignancies Strike 1 in 12 Cancer Patients

0
Second cancer was fatal in 55 percent of the cases studied
Women with a history of cervical intraepithelial neoplasia 2 or 3 have increased risks of subsequent development of anal

Risk of Noncervical Anogenital Cancer Up With History of CIN2/3

0
Women with history of CIN2/3 have increased long-term risk of anal, vulvar, vaginal cancers

June 2016 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for June 2016. This roundup includes...
In 2016

U.S. Cancer Survivors Aging, Battling Other Chronic Disease

0
Likelihood of other chronic conditions will stress health care system in next two decades
The experimental drug midostaurin may reverse organ damage in patients with advanced systemic mastocytosis

Midostaurin Beneficial in Advanced Systemic Mastocytosis

0
Organ damage improved in 60 percent of patients with advanced systemic mastocytosis